Influenza A Virus, H5N1 Subtype

• 

  Subject Areas on Research

  • Absence of neutralizing antibodies against influenza A/H5N1 virus among children in Kamphaeng Phet, Thailand. 
  • Analysis of H5N1 avian influenza infections from wild bird surveillance in Hong Kong from January 2006 to October 2007. 
  • Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. 
  • Avian influenza A (H5N1) infection in a patient in China, 2006. 
  • Avian influenza H5N1 in viverrids: implications for wildlife health and conservation. 
  • Avian influenza and US tv news. 
  • Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. 
  • Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses. 
  • Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004-2008. 
  • Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses. 
  • Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. 
  • Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. 
  • Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. 
  • Emergence and predominance of an H5N1 influenza variant in China. 
  • Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. 
  • Evidence for subclinical H5N1 avian influenza infections among Nigerian poultry workers. 
  • Evidence for subclinical avian influenza virus infections among rural Thai villagers. 
  • Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. 
  • Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. 
  • Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. 
  • Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. 
  • Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development. 
  • Global infections: recognition, management, and prevention. 
  • H5N1 influenza viruses in Lao People's Democratic Republic. 
  • Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China. 
  • Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. 
  • Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes. 
  • Little evidence of subclinical avian influenza virus infections among rural villagers in Cambodia. 
  • Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays. 
  • Molecular epidemiology of H5N1 avian influenza. 
  • Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. 
  • Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein. 
  • Oseltamivir resistance during treatment of influenza A (H5N1) infection. 
  • Programming the magnitude and persistence of antibody responses with innate immunity. 
  • Prospective study of avian influenza virus infections among rural Thai villagers. 
  • Risk Distribution of Human Infections with Avian Influenza H7N9 and H5N1 virus in China. 
  • Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine. 
  • Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. 
  • The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. 
  • The ecology and adaptive evolution of influenza A interspecies transmission. 
  • The emergence and diversification of panzootic H5N1 influenza viruses. 
  • The ethics of care: social workers in an influenza pandemic. 
  • Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). 
  • Virological and epidemiological evidence of avian influenza virus infections among feral dogs in live poultry markets, china: a threat to human health?